Myocardial viability imaging using a novel non-breath-hold cardiac MRI protocol: a comparative assessment with 18F-FDG PET

被引:2
|
作者
Aggarwal, Rohit [1 ]
Singla, Geetika [2 ]
Singh, Harkirat [3 ]
George, Raju Augustine [2 ]
Mukhopadhyay, Indrani [4 ]
机构
[1] 7 Air Force Hosp, Dept Radiol, Nathu Singh Rd,Kanpur Cantonment, Kanpur, Uttar Pradesh, India
[2] Command Hosp Air Force, Dept Radiol, Bangalore, Karnataka, India
[3] Mil Hosp Roorkee, Roorkee, Uttarakhand, India
[4] Armed Forces Med Coll, Dept Obstet & Gynaecol, Pune, Maharashtra, India
关键词
Myocardial viability; Magnetic resonance imaging; Positron emission tomography; LEFT-VENTRICULAR DYSFUNCTION; CORONARY-ARTERY-DISEASE; ENHANCED MAGNETIC-RESONANCE; PROGNOSTIC VALUE; REVASCULARIZATION; IMPACT;
D O I
10.1186/s43055-020-00294-z
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background Delayed contrast enhancement on cardiac magnetic resonance imaging is a well-established MRI technique for the evaluation of myocardial tissue viability. A comprehensive cardiac MRI protocol for myocardial viability comprises of multiple breath hold sequences to provide information regarding chamber volumes, myocardial mass, and function in addition to viability. However, its routine use is limited mainly by lengthy acquisition time and patient's inability to hold breath in multiple breath hold sequences. The important question to which the referring cardiologists/cardiac surgeons are seeking answer is that "What are the viable vascular territories that will benefit from revascularization?" In this study, we have analyzed the utility of non-breath-hold rapid delayed contrast-enhanced cardiac MR imaging protocol for myocardial viability assessment with 18-flourodeoxyglucose positron emission tomography (F-18-FDG PET) as the reference standard. Results Forty patients of ischemic heart disease who met the inclusion criteria were included. All patients underwent both(18)F-FDG PET and delayed contrast-enhanced cardiac magnetic resonance imaging as per the non-breath-hold protocol. In this free-breathing protocol, the breath hold cine sequences were omitted and, after localizers, post-contrast scans were obtained with a time gap of 15 min post-contrast administration. A total number of 680 myocardial segments and corresponding 120 vascular territories were assessed. MRI and(18)F-FDG PET images were analyzed using a 17-segment model as proposed by AHA. Sensitivity, specificity, positive predictive value, and negative predictive value of non-breath-hold rapid delayed contrast-enhanced cardiac MR imaging protocol for assessing myocardial viability (on segment analysis) was 95.5%, 65.59%, 88.0%, and 84.72%, respectively, and of vascular territory analysis were 96.77%, 92.59%, 97.83%, and 89.29%, respectively, in relation to(18)F-FDG PET used as the reference standard. Spearman's rank correlation coefficient is 0.62. Conclusion This modified non-breath-hold delayed contrast-enhanced cardiac MR imaging protocol is a reliable tool to answer the clinically relevant question of myocardial viability with a significant reduction in acquisition time and overcomes the limiting need of breath hold.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Myocardial viability imaging using a novel non-breath-hold cardiac MRI protocol: a comparative assessment with 18F-FDG PET
    Rohit Aggarwal
    Geetika Singla
    Harkirat Singh
    Raju Augustine George
    Indrani Mukhopadhyay
    Egyptian Journal of Radiology and Nuclear Medicine, 51
  • [2] 18F-FDG PET in Myocardial Viability Assessment: A Practical and Time-Efficient Protocol
    Mhlanga, Joyce
    Derenoncourt, Paul
    Haq, Adeel
    Bhandiwad, Anita
    Laforest, Richard
    Siegel, Barry A.
    Dehdashti, Farrokh
    Gropler, Robert J.
    Schindler, Thomas H.
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (04) : 602 - 608
  • [3] 18F-FDG PET and Myocardial Viability Assessment: Trials and Tribulations
    Allman, Kevin C.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 505 - 506
  • [4] 18F-FDG PET Imaging of Myocardial Viability in an Experienced Center with Access to 18F-FDG and Integration with Clinical Management Teams: The Ottawa-FIVE Substudy of the PARR 2 Trial
    Abraham, Arun
    Nichol, Graham
    Williams, Kathryn A.
    Guo, Ann
    deKemp, Robert A.
    Garrard, Linda
    Davies, Ross A.
    Duchesne, Lloyd
    Haddad, Haissam
    Chow, Benjamin
    DaSilva, Jean
    Beanlands, Rob S. B.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51 (04) : 567 - 574
  • [5] The importance of 18F-FDG cardiac PET/CT for the assessment of myocardial viability in ischaemic heart disease A position paper endorsed by the Swiss Society of Nuclear Medicine (SGNM)
    Federico, Caobelli
    Christel, Kamani H.
    Rene, Nkoulou
    Ronny, Buechel R.
    SWISS MEDICAL WEEKLY, 2021, 151
  • [6] Diagnostic value of 18F-FDG PET in the assessment of myocardial viability in coronary artery disease: A comparative study with 99mTc SPECT and echocardiography
    Al Moudi, Mansour
    Sun, Zhong-Hua
    JOURNAL OF GERIATRIC CARDIOLOGY, 2014, 11 (03) : 229 - 236
  • [7] 18F-FDG PET/CT for the Assessment of Myocardial Sarcoidosis
    Skali, Hicham
    Schulman, Allison R.
    Dorbala, Sharmila
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (04)
  • [8] Cardiac 18F-FDG imaging for direct myocardial ischemia imaging
    Goel, Akshay
    Bandyopadhyay, Dhrubajyoti
    He, Zuo-Xiang
    Yang, Min-Fu
    Jain, Diwakar
    JOURNAL OF NUCLEAR CARDIOLOGY, 2022, 29 (06) : 3039 - 3043
  • [9] Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability
    Schinkel, AFL
    Bax, JJ
    Valkema, R
    Elhendy, A
    van Domburg, RT
    Vourvouri, EC
    Bountioukos, MA
    Krenning, EP
    Roelandt, JRTC
    Poldermans, D
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (06) : 877 - 883
  • [10] Assessment of pulmonary nodules using [18F]-FDG PET/CT in deep inspiration breath-hold
    Cepeda, M. S. Casallas
    Cortes, S. Salcedo
    Fernandez, I. Gomez
    Rincon, J. Orcajo
    Berenguer, L. Reguera
    Manjarrez, E. J. Ardila
    Mantilla, J. J. Ardila
    Morales, V. Castillo
    Cruz, J. Guzman
    Rodriguez, D. Zamudio
    Hualde, A. Mari
    Pastor, J. E. Montalva
    Lara, S. Alvarez
    Farto, J. C. Alonso
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2025, 44 (02):